Familial amyloid polyneuropathy and liver transplantation

Journal of Hepatology

Volumn 41, Issue 2, 2004, Pages 188-194

  Monteiro, Estela ^a,b   Freire, António ^a   Barroso, Eduardo ^a  

^a HOSPITAL CURRY CABRAL   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE SEVERITY; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 4444379180     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.004     Document Type: Review

References (52)

1. Andrade C. A peculiar form of peripheral neuropathy. Acta Psych et Neurol Scand. 26:1951;251-257
2. Andrade C. Note preliminaire sur une forme particuliere de neuropathie peripherique. Rev Neurol. 85:1951;302-306
3. Andrade C. Clinique de la paramyloidose du type portugais. Acta Neuropathol (Berl). Suppl II:1963;3-11
4. Becker P.E., Antunes L., Rosario M.R., Barros F. Paramyloidose der peripheren nerven in Portugal. Z menschl vereb-ukonstitutionslehre. 37:1964;329-364
5. Costa P.P., Figueira A.S., Bravo F. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA. 75:1978;4499-4503
6. Glenner G.G. Amyloid deposits and amyloidosis. The B-fibrilloses. N Engl J Med. 302:1980;1283-1292
7. Saraiva M.J.M., Birken S., Costa P.P., Goodman D.S. Amyloid fibril protein in familial amyloidotic polyneuropathy Portuguese type. Definition of molecular abnormality in transthyretin (pre-albumin). J Clin Invest. 74:1984;104-119
8. Saraiva M.J.M., Birken S., Costa P.P., Goodman D.S. Family studies of the genetic abnormality in transthyretin (pre-albumin) in Portuguese patients with familial amyloidotic polyneuropathy. Ann NY Acad Sci. 435:1984;86-100
9. Saraiva M.J.M., Costa P.P., Goodman D.S. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (pre-albumin)-methionine-30 variant. J Clin Invest. 76:1985;2171-2177
10. Monteiro E., Perdigoto R., Furtado A.L. Liver transplantation for familial amyloid polyneuropathy. Hepato-Gastroenterology. 45:1998;1375-1380
11. Andrade C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 75:1952;408-427
12. Suhr O.B., Ericzon B.-G., Friman S. Longterm follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl Surg. 2002;787-794
13. Steen L., Ek B. Familial amyloidosis with polyneuropathy. A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand. 214:1983;387-397
14. Suhr O., Danielsson A., Holmgren G., Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med. 235:1994;479-485
15. Anderrson R. Familial amyloidosis with polyneuropathy: a clinical study based on patients living in northern Sweden. Acta Med Scand. 198:1976;1-64
16. Sales Luis M.L., Galvão M., Carvalho M., Sousa G., Alves M.M., Serrão R. Treatment of familial amyloidotic polyneuropathy (Portuguese type) by plasma exchange. Muscle Nerve. 1991;377-378
17. Lobato L, Costa PMP, Castro R, Beirão I, Estacio A, Costa PP. In vivo immunoadsorption of transthyretin in familial amyloidotic polyneuropathy TTR-Met 30: preliminary clinical experience. Proceedings of the 3rd International Symposium on Familial Amyloidotic Polyneuropathy and other Transthyretin Related Disorders. Lisboa, Portugal; 1995.
18. Holmgren G., Steen L., Ekstedt J., Groth C.G., Ericzon B.-G., Eriksson S., et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-Met30). Clin Genet. 40:1991;242-246
19. Holmgren G., Ericzon B.-G., Groth C.G., Steen L., Suhr Andersen O., Wallin B.G., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 341:1993;1113-1116
20. Herlenius G., Wilezek H.E., Larsson M., Ericzon B.-G. Ten years of International experience with liver transplantation for familial amyloidotic polineuropathy: results from the familial amyloidotic polyneuropathy World Transplant Registry. Transplantation. 77:2004;64-71
21. Monteiro E., Perdigoto R., Morbey A., Mota O., Ribeiro T., Freire A., et al. Portuguese national experience in familial amyloid polyneuropathy (FAP) treated by orthotopic liver transplant. Hepatology. 22:1995;149A
22. Suhr O., Holmgren G., Steen L., Wikstrom L., Norden G., Friman S., et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation. 60:1995;933-938
23. Suhr O.B., Hernelius G., Friman S., Ericzon B.-G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl. 6:2000;263-276
24. Ikeda S., Takai Y., Yanagisawa N., Matsunami H., Hashikura Y., Ikegami T., et al. Partial liver transplantation from living donors in familial amyloid polyneuropathy. Amyloid. 4:1997;18-23
25. Skinner M., Lewis W., Jons L., Kasirsky J., Kane K., Ju S.-T., et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Int Med. 120:1994;133-134
26. Lewis W., Skinner M., Jenkins R. Report on 24 patients with liver transplantation for FAP in the United States (abstract). Neuromuscul Disord. 6:1996;77A
27. Parilla P., Ramirez P., Bueno F., Robles R., Acosta F., Miras M., et al. Clinical improvement after liver transplantation for type 1 familial amyloid polyneuropathy. Br J Surg. 82:1995;825-828
28. Adams D., Samuel D., Goulon-Goeau C., Costa P., Nakazzato M., Costa P.M.P., et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain. 123:2000;1495-1504
29. Suhr O., Danielsson A., Rydh A., Nyhlin N., Hietale S.O., Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci. 10:1996;1909-1914
30. Suhr O., Danielsson A., Holmgren G., Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med. 235:1994;479-485
31. Hagerman I., Berglund L., Ericzon B.-G., Eleborg L. Total pharmacologic autonomic blockade (TAB) reveals severe autonomic imbalance of heart rate variability (HRV) in familial amyloidotic polyneuropathy (abstract). Proc Int Workshop Liver Transpl FAP. 10:1999;22
32. Grazi G.L., Cescon M., Salvi F., Ercolani G., Ravaioli M., Arpesella G., et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transpl. 9:2003;986-992
33. Kobayashi S., Movita H., Asawa T., Takei Y.I., Hashimoto T., Ikegami T., et al. Peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation. Amyloid. 10:2003;17-24
34. Dubrey S.W., Davidoff R., Kinnar M., Bergethon P., Lewis D., Falk R.H. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation. 64:1997;74-80
35. Tashimo K., Ando Y., Terazaki H., Yoshimatsu S., Suhr O.B., Obayashi K., et al. Outcome of liver transplantation for transthyretin amyloidosis; Follow-up of Japanese familial amyloidotic polyneuropathy patients. J. Neurol Sci. 171:1999;19-23
36. Sharma P., Perri R.E., Sirven J.E., Zeldenrust S., Brand hagen D.J., Rosen C.B., et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl. 12:2003;1273-1280
37. Stangou A.J., Hawkins P.N., Heaton N.D., Rela M., Monaghan M., Nihoyannopoulos P., et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation. 66:1998;229-233
38. Pomfret E.A., Lewis W.D., Jenkins R.L., Bergelhon P., Dubrey S.W., Reisinger J., et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 65:1998;918-925
39. Suhr O. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients symptoms and complications. Amyloid. 10:2003;77-83
40. Ando Y., Terazaki H., Nakamura M., Ando E., Haraok K., Yamashila T., et al. A different amyloid formation mechanism: de novo oculo leptomeningeal amyloid deposits after liver transplantation. Transplantation. 77:2004;345-349
41. Furtado AJL. Sequential liver transplantation. Proceedings of the: second International Workshop on Liver Transplantation in Familial Amyloidotic Polyneuropathy. Lisbon; 1995.
42. Furtado A., Tomé L., Oliveira F.J., Furtado E., Viana J., Perdigoto R. Sequential liver transplantation. Transpl Proc. 29:1997;467-468
43. Hesse U., Troisi R., Mortier E., Decruyenaere J., de Hemptinne B. Sequencial orthotopic liver transplantation: domino transplantation. Chirurg. 68:1997;1011-1013
44. Hemming A.W., Catral M.S., Shari R.S., Greyg P.D., Lilly L.B., Ashby P., et al. Domino liver transplantation for familial amyloid polyneuropathy. Liver Transpl Surg. 4:1998;236-238
45. Schmidt H.H.-J., Nashan B., Propsting M.J., Nakazato M., Flemming P., Kubicka S., et al. Familial amyloidotic polyneuropathy: domino liver transplantation. J Hepatol. 30:1999;293-298
46. Azoulay D., Samuel D., Castaing D., Adam R., Adams D., Said G., et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg. 189:1999;584-593
47. Furtado A.J.L. Domino liver transplantation using livers from patients with familial amyloidotic polyneuropathy. Curr Opin Org Transpl. 5:2000;69-73
48. Pena J.R., Barroso E., Martins A., Andrade J.R., Pereira J.P. Sequential whole liver transplant resected as piggy-back from FAP patients (abstract). Liver Transpl. 8:2002;C-24
49. Pacheco Moreira L.F., Oliveira M.E., Balbi E., Cerqueira da Silva A., Miecznikowski R., de Faria L.J.A. A new technical options for domino liver transplantation. Liver Transpl. 9:2003;632-633
50. Carrera M.T., Bogue E.H. Domino liver transplantation: a practical option in the face of the organ shortage. Prog Transpl. 13:2003;151-153
51. Bittencourt P.L., Couto C.A. No evidence of de novo amyloidosis in recipients of domino liver transplantation: 12 to 40 (mean 24) months follow-up. Amyloid. 9:2002;194-196
52. Sousa M.M., Ferrão J., Fernandes R., Guimarães A., Geraldes J.B., Perdigoto R., et al. Deposition and passage of transthyretine through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. Laboratory Investigation. 84:2004;865-873